University Hospital Cologne
Cologne, Germany 
Head of the Department
Prof. Dr. Michael Hallek
Department of Hematology, Oncology and Infectious Diseases
Department of Hematology, Oncology, and Infectious Diseases at University Hospital Cologne provides care for patients with blood diseases, coagulation disorder, tumors, and infectious diseases. The department has been recognized by the German Accreditation Body as a laboratory for molecular hematology and oncology that focuses on the early diagnosis and treatment of cancer of the esophagus, stomach, intestine, lung as well as sarcomas. The medical staff has achieved impressive results in the field of oncology that the facility has been certified by the German Cancer Aid and German Cancer Society.
Under the leadership of Prof. Dr. Med. Michael Hallek, the medical staff treats more than 3,000 inpatients every year, many of which receive care in the hematology unit that offers the full range of care for leukemia, lymphoma, and myelodysplastic syndromes, including immunosuppressive therapy.
The Department of Hematology, Oncology, and Infectious Diseases at University Hospital Cologne is specialized in the diagnosis and treatment of:
- Acute leukemia
- Chronic leukemia
- Myelodysplasia
- Myeloproliferative disorders
- Hodgkin’s lymphoma
- Non-Hodgkin's lymphoma
- Hemorrhagic tendency
- Hypercoagulability
- Myeloma
- Aplastic anemia
- Iron deficiency anemia
- HIV
- Syphilis
- Chlamydia
- Gonorrhea
- Trichomoniasis
- Tuberculosis
- Ringworm
- Athlete's foot
Education and Professional Career
- since 2007: Director, Center for Integrated Oncology CIO, Universities of Cologne and Bonn, since 2019, Universities of Aachen Bonn Cologne Düsseldorf
- since 2003: C4-Professor, University of Cologne
- 1999-2003: C3-Professor, University of Munich
- 1998-2005: Head, Clinical Cooperation Group GSF (Helmholtz Institute) Munich
- 1995-2003: Senior Consultant, University of Munich
- 1994-2005: Research Group Leader, Gene Center Munich
- 1990-1992: Research Associate, Dana Farber Cancer Institute, Harvard Medical School, USA
- 1985-2003: Residences and training in pharmacology, internal medicine, hematology and oncology at the Technical University (Rechts der Isar Hospital) and University of Munich (Innenstadt and Grosshadern Hospitals)
Awards, Distinctions, and Additional Professional Activities
- since 2020: Associate Editor of BLOOD
- since 2019: Co-Chair, Strategy Advisory Board “National Decade against Cancer”, Federal Ministry of Education and Research (BMBF)
- since 2019: Member of the Supervisory Board of the University Hospital Munich
- since 2019: President, Walter-Siegenthaler Society
- 2019: José Carreras Award of the European Hematology Association
- since 2018: Chairman Scientific Committee, European School of Haematology, Paris
- 2018: Ham-Wasserman Lecture, American Society of Hematology
- 2018: Johann-Georg-Zimmermann Award
- 2017: Arthur Burkhardt Award
- 2017: German Cancer Award
- 2016: Walter-Siegenthaler Medal in gold
- 2016-2019: Chairman and 2018-2019 Executive Chairman, German Society of Hematology and Medical Oncology DGHO
- since 2014: Scientific Board Member and Vice-Chairman (since 2019), German Chamber of Physicians
- 2014-2017: Scientific Committee of the American Society of Hematology
- 2014-2015: President, German Society of Internal Medicine DGIM
- 2014: President of the German Cancer Congress
- 2013: Binet-Rai Medal of the International Workshop on CLL iwCLL
- 2013-2019: Chairman, Clinical Research Unit 286 “DNA damage response in CLL” (DFG)
- 2013-2016: Senate Commission “Grundsatzfragen der Klinischen Forschung”, German Research Foundation (DFG)
- 2012: Paul-Martini Award
- 2011-2019: Editor-in-Chief “Oncology Research and Treatment”
- since 2011: Member of the National Academy of Sciences, Leopoldina
- 2009-2014: Chairman, Collaborative Research Center 832 “Tumor Microenvironment”
- since 2008: Center of Excellence in Oncology Award, Center for Integrated Oncology CIO Cologne-Bonn
- since 2000: Scientific Committee Member, International Working Group on CLL (iwCLL), Chair since 2015
- 1999: Artur-Pappenheim Award, German Society of Hematology and Oncology
- since 1996: Founder and Chairman of the German CLL Study Group
Publications
Department of Hematology, Oncology and Infectious Diseases
Receive an offer for Treatments
